BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2024 9:36:31 AM | Browse: 85 | Download: 443
 |
Received |
|
2024-03-01 22:18 |
|
Peer-Review Started |
|
2024-03-01 22:18 |
|
First Decision by Editorial Office Director |
|
2024-04-30 02:53 |
|
Return for Revision |
|
2024-04-30 02:53 |
|
Revised |
|
2024-05-14 01:54 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-07-22 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-07-23 09:54 |
|
Articles in Press |
|
2024-07-23 09:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-12 00:49 |
|
Publish the Manuscript Online |
|
2024-08-22 09:36 |
| ISSN |
2150-5330 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shahid Habib |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shahid Habib, FCPS, MBBS, MRCP, Researcher, Department of Hepatology, Liver Institute PLLC, 2830 N Swan Road, Suite 180, Tucson, AZ 85712, United States. shabib@liverinstitutepllc.org |
| Key Words |
Pathogenesis; Dyslipidemia; Diabetes; TM6SF2; PNPLA3; Genetics; Glucagon-like peptide-1; Adiponectin; Insulin; Peroxisome proliferator-activated receptor; Farnesoid X receptor; Obesity; Visceral adiposity; Metabolic dysfunctions-associated steatotic liver disease |
| Core Tip |
The pathogenesis of metabolic dysfunctions associated steatotic liver disease (MASLD) is complex and a thorough analysis of the contributing factors to disease progression is pivotal to individualized patient care. Understanding and identifying the key pathogenic processes responsible for MASLD in each patient allows for the utilization of appropriate and effective pharmacotherapy. This review details the various key players in MASLD pathogenesis, through the lens of carbohydrate and fat metabolism, to divulge new areas of focus that could strengthen the capability of precision medicine for this population of patients. |
| Publish Date |
2024-08-22 09:36 |
| Citation |
Habib S. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy. World J Gastrointest Pathophysiol 2024; 15(4): 93606 |
| URL |
https://www.wjgnet.com/2150-5330/full/v15/i4/93606.htm |
| DOI |
https://dx.doi.org/10.4291/wjgp.v15.i4.93606 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
